Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of CBD vs THC and Alprazolam
NCT03398083Phase 1Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Dec 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabidiol (6 arms), sponsored by National Institute on Drug Abuse. Primary endpoint: Visual Analog Scale at 18 days. Started Dec 2017; status: completed.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on NCT03398083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03398083.